Anderson, Christopher. "Minnesota Kills Controversial Drug," Science 263 (25 March 1994), p.
This is an announcement of Minnesota's closing of its ALG program. Some of the "facts"
reported here: ALG has generated $60 million in revenues since the program started in 1971; the
head of the program, John Najarian, has resigned and is under grand jury investigation; in 1992,
the program was halted by the FDA; the university was unable to find a buyer for the drug.
But the substance of this interpretation of events is that patients will suffer and Minnesota has
been abused by the FDA. It is a very selective interpretation. (The other losses Dean, a VP or
two, are not mentioned.)